On (b)(6) 2017 our affiliate in (b)(6) received an email from a patient (pt) who reported eye pain (affected eye not provided), sought medical attention, and purchased over-the-counter eye drops.The pt reported the ¿vision was also less visible¿.On 06nov2017 and 09nov2017 the affiliate attempted to reach the pt by telephone, but they were unable to reach the pt.On 25nov2017 the affiliate placed a call to the pt and additional information was received: the pt reported the suspect product is acuvue oasys for astigmatism brand contact lenses.The pt reported the event occurred in (b)(6) 2017 and the affected eye is the left eye.The pt went to an eye care provider (ecp) as redness persisted after the suspect lens was removed.The pt reported that the ecp ¿assumed that bacteria might have come into the eye¿.The pt was prescribed sanbetason ophthalmic, otorhinologic solution and cravit ophthalmic solution.The pt reported there was no instructions to discontinue lens wear or return to the clinic.Currently, the pt has no left eye symptoms.The suspect lens was discarded.No additional medical information was received and no additional medical information is expected.This left eye event will be reported as a worst-case event as the diagnosis was not verified by the pts treating ecp.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00mlnb was produced under normal conditions.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|